All content on this site is intended for healthcare professionals only. By acknowledging this message and accessing the information on this website you are confirming that you are a healthcare professional.
The SOT Hub website uses a third-party service provided by Google that dynamically translates web content. Translations are machine generated, so may not be an exact or complete translation, and the SOT Hub cannot guarantee the accuracy of translated content. The SOT Hub and its employees will not be liable for any direct, indirect, or consequential damages (even if foreseeable) resulting from use of the Google Translate feature. For further support with Google Translate, visit Google Translate Help.
The SOT Hub is an independent medical education platform, supported through a founding grant from Therakos. Funders are allowed no direct influence on our content. The levels of sponsorship listed are reflective of the amount of funding given. View funders.
Now you can support HCPs in making informed decisions for their patients
Your contribution helps us continuously deliver expertly curated content to HCPs worldwide. You will also have the opportunity to make a content suggestion for consideration and receive updates on the impact contributions are making to our content.
Find out more
Create an account and access these new features:
Bookmark content to read later
Select your specific areas of interest
View solid organ transplantation content recommended for you
Results from a retrospective study of data from the United Network for Organ Sharing (UNOS), evaluating outcomes following isolated heart transplantation (IHT; n = 48,069), simultaneous heart-kidney transplantation (SHKT; n = 2,345), or kidney-after-heart transplantation (KAH; n = 667), were published in the Journal of the American Heart Association by Yajima et al. The primary outcome was post-transplant survival.
Key data: Survival rates were higher in patients who received SHKT vs IHT (1‑year, 88.0% vs 85.7%; 5‑year, 70.5% vs 64.1%; 10‑year, 38.1% vs 30.3%; overall p = 0.005). Compared with KAH, SHKT was associated with lower short-term survival (1‑year, 86.6% vs 94.4%; p = 0.002) but higher long-term survival (5‑year, 72.1% vs 61.9%; p = 0.047; 10‑year, 42.9% vs 15.8%; p < 0.001). Prior dialysis (odds ratio [OR], 2.264), younger recipient age (OR, 0.879), pre-IHT diabetes (OR, 1.361), higher body mass index (BMI; OR, 0.979), and lower estimated glomerular filtration rate (eGFR; OR, 1.449) were identified as risk factors for post‑IHT isolated kidney transplantation (IKT).
Key learning: SHKT may improve long-term survival compared with IHT or KAH, supporting its consideration as an upfront transplantation strategy in selected patients.
References
Please indicate your level of agreement with the following statements:
The content was clear and easy to understand
The content addressed the learning objectives
The content was relevant to my practice
I will change my clinical practice as a result of this content